- Home
- FUTU vs DXCM Comparison
FUTU vs DXCM Comparison
Compare FUTU & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUTU | DXCM |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 25.9B |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FUTU | DXCM |
|---|---|---|
| Price | $171.11 | $67.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 21 |
| Target Price | ★ $208.60 | $87.90 |
| AVG Volume (30 Days) | 1.5M | ★ 5.3M |
| Earning Date | 11-18-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.17 | 7.75 |
| EPS | ★ 8.95 | 1.80 |
| Revenue | $2,442,834,991.00 | ★ $4,515,900,000.00 |
| Revenue This Year | $87.24 | $17.41 |
| Revenue Next Year | $13.85 | $12.78 |
| P/E Ratio | ★ $19.17 | $37.27 |
| Revenue Growth | ★ 87.15 | 14.21 |
| 52 Week Low | $70.60 | $54.11 |
| 52 Week High | $202.53 | $93.25 |
Technical Indicators
Market Signals| Indicator | FUTU | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 60.62 |
| Support Level | $166.60 | $64.00 |
| Resistance Level | $175.77 | $69.77 |
| Average True Range (ATR) | 5.39 | 1.96 |
| MACD | 0.59 | 0.78 |
| Stochastic Oscillator | 51.53 | 72.06 |
Price Performance
Historical ComparisonAbout FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and the United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services, and interest income.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.